{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:58:27Z","timestamp":1789754307758,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA265735"],"award-info":[{"award-number":["U01CA265735"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA453475"],"award-info":[{"award-number":["R01CA453475"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma (MM) is a hematological malignancy that is consistently preceded by an asymptomatic condition, monoclonal gammopathy of undetermined significance (MGUS). Disparities by age, gender, and race\/ethnicity in both MGUS and MM are well-established. However, it remains unclear whether these disparities can be explained by increased incidence of MGUS and\/or accelerated progression from MGUS to MM. Here, we fit a mathematical model to nationally representative data from the United States and showed\u00a0that the difference in MM incidence can be explained by an increased incidence of MGUS among male and non-Hispanic Black populations. We did not find evidence showing differences in the rate of progression from MGUS to MM by either gender or race\/ethnicity. Our results suggest that screening for MGUS\u00a0among high-risk groups (e.g., non-Hispanic Black men) may hold promise as a\u00a0strategy\u00a0to reduce the burden and MM health disparities.<\/jats:p>","DOI":"10.1038\/s41467-023-41223-8","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T06:02:01Z","timestamp":1695189721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-5187","authenticated-orcid":false,"given":"John H.","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1205-0369","authenticated-orcid":false,"given":"Mengmeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2029-8230","authenticated-orcid":false,"given":"Yi-Hsuan","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-0291","authenticated-orcid":false,"given":"Graham","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-9556","authenticated-orcid":false,"given":"Su-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"41223_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"41223_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan, A. J. et al. Diagnosis and Management of Multiple Myeloma: A Review. JAMA 327, 464\u2013477 (2022).","journal-title":"JAMA"},{"key":"41223_CR3","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle, R. A. et al. Prevalence of Monoclonal Gammopathy of Undetermined Significance. N. Engl. J. Med 354, 1362\u20131369 (2006).","journal-title":"N. Engl. J. Med"},{"key":"41223_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","volume":"24","author":"RA Kyle","year":"2010","unstructured":"Kyle, R. A. et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24, 1121\u20131127 (2010).","journal-title":"Leukemia"},{"issue":"Suppl","key":"41223_CR5","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.clml.2014.05.004","volume":"14","author":"C Bories","year":"2014","unstructured":"Bories, C. & Jagannath, S. Asymptomatic monoclonal gammopathies. Clin. Lymphoma Myeloma Leuk. 14(Suppl), S78\u201386 (2014).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"41223_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.blre.2009.07.004","volume":"23","author":"S Madan","year":"2009","unstructured":"Madan, S. & Greipp, P. R. The incidental monoclonal protein: Current approach to management of monoclonal gammopathy of undetermined significance (MGUS). Blood Rev. 23, 257\u2013265 (2009).","journal-title":"Blood Rev."},{"key":"41223_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-020-0284-7","volume":"10","author":"CR Marinac","year":"2020","unstructured":"Marinac, C. R., Ghobrial, I. M., Birmann, B. M., Soiffer, J. & Rebbeck, T. R. Dissecting racial disparities in multiple myeloma. Blood Cancer J. 10, 1\u20138 (2020).","journal-title":"Blood Cancer J."},{"key":"41223_CR8","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1182\/bloodadvances.2021006201","volume":"6","author":"CM Vachon","year":"2022","unstructured":"Vachon, C. M. et al. Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method. Blood Adv. 6, 3746\u20133750 (2022).","journal-title":"Blood Adv."},{"key":"41223_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","volume":"28","author":"O Landgren","year":"2014","unstructured":"Landgren, O. et al. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey. Leukemia 28, 1537\u20131542 (2014).","journal-title":"Leukemia"},{"key":"41223_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1182\/blood.V106.11.1541.1541","volume":"106","author":"O Landgren","year":"2005","unstructured":"Landgren, O. et al. Risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Multiple Myeloma among African-American and White Veterans in the U.S. Blood 106, 1541 (2005).","journal-title":"Blood"},{"key":"41223_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2141.2012.09124.x","volume":"158","author":"S Ailawadhi","year":"2012","unstructured":"Ailawadhi, S. et al. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups. Br. J. Haematol. 158, 91\u201398 (2012).","journal-title":"Br. J. Haematol."},{"key":"41223_CR12","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","volume":"116","author":"AJ Waxman","year":"2010","unstructured":"Waxman, A. J. et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 116, 5501\u20135506 (2010).","journal-title":"Blood"},{"key":"41223_CR13","doi-asserted-by":"publisher","first-page":"djw264","DOI":"10.1093\/jnci\/djw264","volume":"109","author":"SH Chang","year":"2017","unstructured":"Chang, S. H. et al. Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study. JNCI J. Natl Cancer Inst. 109, djw264 (2017).","journal-title":"JNCI J. Natl Cancer Inst."},{"key":"41223_CR14","unstructured":"Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data. Published online 1999. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=1999."},{"key":"41223_CR15","unstructured":"Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data. Published online 2001. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2001."},{"key":"41223_CR16","unstructured":"Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey Data. Published online 2003. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2003."},{"key":"41223_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1022268103136","volume":"22","author":"M Benjamin","year":"2003","unstructured":"Benjamin, M., Reddy, S. & Brawley, O. W. Myeloma and race: a review of the literature. Cancer Metastasis Rev. 22, 87\u201393 (2003).","journal-title":"Cancer Metastasis Rev."},{"key":"41223_CR18","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","volume":"116","author":"O Landgren","year":"2010","unstructured":"Landgren, O. et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood 116, 1056\u20131059 (2010).","journal-title":"Blood"},{"key":"41223_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41408-020-0314-5","volume":"10","author":"CM Bunce","year":"2020","unstructured":"Bunce, C. M. & Drayson, M. T. Dissecting racial disparities in multiple myeloma\u2014clues from differential immunoglobulin levels. Blood Cancer J. 10, 1\u20132 (2020).","journal-title":"Blood Cancer J."},{"key":"41223_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15740-9","volume":"11","author":"EH Rustad","year":"2020","unstructured":"Rustad, E. H. et al. Timing the initiation of multiple myeloma. Nat. Commun. 11, 1917 (2020).","journal-title":"Nat. Commun."},{"key":"41223_CR21","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/jnci\/djab074","volume":"113","author":"EA Waters","year":"2021","unstructured":"Waters, E. A., Colditz, G. A. & Davis, K. L. Essentialism and Exclusion: Racism in Cancer Risk Prediction Models. JNCI J. Natl Cancer Inst. 113, 1620\u20131624 (2021).","journal-title":"JNCI J. Natl Cancer Inst."},{"key":"41223_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","volume":"87","author":"TM Therneau","year":"2012","unstructured":"Therneau, T. M. et al. Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition. Mayo Clin. Proc. 87, 1071\u20131079 (2012).","journal-title":"Mayo Clin. Proc."},{"key":"41223_CR23","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S2352-3026(14)00037-4","volume":"2","author":"SH Chang","year":"2015","unstructured":"Chang, S. H. et al. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study. Lancet Haematol. 2, e30\u201336 (2015).","journal-title":"Lancet Haematol."},{"key":"41223_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1158\/1940-6207.CAPR-13-0224","volume":"7","author":"BM Birmann","year":"2014","unstructured":"Birmann, B. M., Giovannucci, E. L., Rosner, B. A. & Colditz, G. A. Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses\u2019 health study. Cancer Prev. Res Philos. Pa. 7, 33\u201341 (2014).","journal-title":"Cancer Prev. Res Philos. Pa."},{"key":"41223_CR25","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle, R. A. et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N. Engl. J. Med 356, 2582\u20132590 (2007).","journal-title":"N. Engl. J. Med"},{"key":"41223_CR26","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Time Dependent (1990-2019) Income\/Rurality, 1969-2020 Counties. Published online April 2022."},{"key":"41223_CR27","unstructured":"National Center for Health Statistics (NCHS). Bridged-Race Population Estimates, United States July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin. Compiled from 1990-1999 bridged-race intercensal population estimates (released by NCHS on 7\/26\/2004); revised bridged-race 2000-2009 intercensal population estimates (released by NCHS on 10\/26\/2012); and bridged-race Vintage 2020 (2010-2020) postcensal population estimates (released by NCHS on 9\/22\/2021). http:\/\/wonder.cdc.gov\/bridged-race-v2020.html."},{"key":"41223_CR28","unstructured":"National Center for Health Statistics (NCHS). National Population Projections: United States by Age, Gender, Ethnicity and Race for years 2014-2060, released by the U.S. Census Bureau on December 10, 2014, on CDC WONDER Online Database. Published online 2015. http:\/\/wonder.cdc.gov\/population-projections-2014-2060.html."},{"key":"41223_CR29","unstructured":"Arias, E. United States Life Tables, 2010. Natl Vital Stat Rep 63, https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr63\/nvsr63_07.pdf (2014)."},{"key":"41223_CR30","unstructured":"Hartig, F., Minunno, F., Paul, S., Cameron, D. & Ott, T. BayesianTools: General-purpose MCMC and SMC samplers and tools for Bayesian statistics. Published online 2019."},{"key":"41223_CR31","doi-asserted-by":"publisher","unstructured":"Gelman, A., & Rubin, D. B. Inference from Iterative Simulation Using Multiple Sequences. Stat Sci. 7 https:\/\/doi.org\/10.1214\/ss\/1177011136 1992","DOI":"10.1214\/ss\/1177011136"},{"key":"41223_CR32","doi-asserted-by":"publisher","unstructured":"Huber, J. et al. Disentangling age, gender, and racial\/ethnic disparities in multiple myeloma burden: a modeling study. https:\/\/doi.org\/10.5281\/zenodo.8244914.","DOI":"10.5281\/zenodo.8244914"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41223-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41223-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T10:11:43Z","timestamp":1700129503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41223-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41223"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-41223-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"17 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5768"}}